Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Williams Companies
WMB
|
+$329M |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$256M |
| 3 |
Deutsche Bank
DB
|
+$250M |
| 4 |
DuPont de Nemours
DD
|
+$233M |
| 5 |
Ventas
VTR
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$422M |
| 2 |
Prologis
PLD
|
+$355M |
| 3 |
Johnson & Johnson
JNJ
|
+$335M |
| 4 |
Procter & Gamble
PG
|
+$319M |
| 5 |
NXP Semiconductors
NXPI
|
+$289M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.66% |
| 2 | Financials | 12.59% |
| 3 | Healthcare | 12.16% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WFBI
1851
DELISTED
WashingtonFirst Bankshares Inc
WFBI
| $4.79M | ﹤0.01% |
138,801
+117,160
| +541% | +$3.62M |
|
1852
Zumiez
ZUMZ
$330M
| $4.78M | ﹤0.01% |
387,249
+373,782
| +2,776% | +$5.71M |
|
|
ATRI
1853
DELISTED
Atrion Corp
ATRI
| $4.77M | ﹤0.01% |
7,423
+4,161
| +128% | +$2.24M |
|
1854
Bruker
BRKR
$9.4B
| $4.77M | ﹤0.01% |
165,487
+115,061
| +228% | +$2.96M |
|
1855
US Physical Therapy
USPH
$1.22B
| $4.76M | ﹤0.01% |
78,889
+74,204
| +1,584% | +$4.74M |
|
1856
WesBanco
WSBC
$4.02B
| $4.76M | ﹤0.01% |
120,452
+6,596
| +6% | +$256K |
|
1857
The Greenbrier Companies
GBX
$1.57B
| $4.75M | ﹤0.01% |
102,784
-252,106
| -71% | -$11.5M |
|
1858
Community Bank
CBU
$3.39B
| $4.75M | ﹤0.01% |
85,214
+12,504
| +17% | +$692K |
|
1859
Gray Television
GTN
$437M
| $4.75M | ﹤0.01% |
346,848
-67,012
| -16% | -$904K |
|
|
VSTO
1860
DELISTED
Vista Outdoor Inc.
VSTO
| $4.75M | ﹤0.01% |
211,059
-307,560
| -59% | -$6.49M |
|
1861
Stride
LRN
$4.16B
| $4.74M | ﹤0.01% |
264,815
+40,098
| +18% | +$769K |
|
|
CONE
1862
DELISTED
CyrusOne Inc Common Stock
CONE
| $4.74M | ﹤0.01% |
85,173
+6,986
| +9% | +$386K |
|
|
TIVO
1863
DELISTED
Tivo Inc
TIVO
| $4.74M | ﹤0.01% |
254,186
+10,343
| +4% | +$188K |
|
|
PGNX
1864
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $4.74M | ﹤0.01% |
697,834
+230,110
| +49% | +$1.7M |
|
|
NVMI
1865
Nova
NVMI
$11.7B
| $4.73M | ﹤0.01% |
214,139
+72,286
| +51% | +$1.61M |
|
1866
Vanda Pharmaceuticals
VNDA
$304M
| $4.73M | ﹤0.01% |
290,230
-12,259
| -4% | -$177K |
|
|
AUD
1867
DELISTED
Audacy, Inc.
AUD
| $4.72M | ﹤0.01% |
456,419
+273,448
| +149% | +$3.08M |
|
|
MB
1868
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $4.69M | ﹤0.01% |
172,642
+106,688
| +162% | +$2.93M |
|
|
CYS
1869
DELISTED
CYS Investments Inc.
CYS
| $4.68M | ﹤0.01% |
556,609
+458,430
| +467% | +$3.85M |
|
1870
Frontline
FRO
$8.71B
| $4.68M | ﹤0.01% |
816,169
+577,469
| +242% | +$3.55M |
|
1871
MasTec
MTZ
$22.7B
| $4.67M | ﹤0.01% |
103,547
-330,386
| -76% | -$14.3M |
|
1872
Q2 Holdings
QTWO
$3.78B
| $4.67M | ﹤0.01% |
126,564
+83,038
| +191% | +$3.15M |
|
|
RPT
1873
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $4.67M | ﹤0.01% |
362,023
+98,890
| +38% | +$1.31M |
|
|
SGYP
1874
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $4.66M | ﹤0.01% |
1,046,905
+738,906
| +240% | +$3.05M |
|
|
PSXP
1875
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $4.64M | ﹤0.01% |
94,040
-35,796
| -28% | -$1.81M |
|
Similar funds
Deutsche Bank's Q2 2017 Portfolio in Review
As of Q2 2017, Deutsche Bank held 5,434 positions worth $140B, up 3.5% from $135B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Deutsche Bank's Q2 2017 filing shows 372 new, 2,839 increased, 1,383 reduced and 348 closed positions. Its largest new stake was Altaba Inc: 2,405,742 shares worth $131M. The largest sale was Apple, an estimated $422M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Financials and Healthcare.
- Deutsche Bank's largest Q2 2017 buy was Altaba Inc: 2,405,742 shares worth $131M.
- Deutsche Bank added most to Williams Companies in Q2 2017, an estimated $329M increase.
- Deutsche Bank's biggest Q2 2017 reduction was Apple, cutting an estimated $422M.
- Deutsche Bank fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $242M.
- Deutsche Bank's ten largest holdings make up 11% of its $140B portfolio in Q2 2017.
- Deutsche Bank opened 372 new positions and closed 348 in Q2 2017.
- Deutsche Bank's portfolio value rose 3.5% quarter-over-quarter to $140B.
Based on Deutsche Bank's 13F filing for Q2 2017, filed 11 Aug 2017.